您的位置: 首页 > 农业专利 > 详情页

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
专利权人:
Inc.;Moderna Therapeutics
发明人:
SCHRUM, Jason P.,AFEYAN, Noubar B.,SIECZKIEWICZ, Gregory J.,BANCEL, Stephane,DE FOUGEROLLES, Antonin,ELBASHIR, Sayda M.,EJEBE, Kenechi
申请号:
AU2019240643
公开号:
AU2019240643A1
申请日:
2019.10.02
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
#$%^&*AU2019240643A120191024.pdf#####Abstract Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic 5 acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins. W: NRPortbl GHMatters MICHELES 7430647_1.docx 17/02/169/17 Figure 7 A. Human EPO Protein in Mouse Serum (I.M. Injection Route) 150I Epo-Lipoplex 100- = Luc-Lipoplex EIM Epo-Saline fD "= Luc-Saline 50- I F.Buffer 0 Treatment Groups B. Human EPO Protein in Mouse Serum (S.C. Injection Route) 2015- Epo-Lipoplex M Luc-Lipoplex E = Epo-Saline 10 = Luc-Saline UL F.Buffer T I Treatment Groups
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充